[PDF] The Impact Of Off Label Compassionate And Unlicensed Use On Health Care Laws In Preselected Countries - eBooks Review

The Impact Of Off Label Compassionate And Unlicensed Use On Health Care Laws In Preselected Countries


The Impact Of Off Label Compassionate And Unlicensed Use On Health Care Laws In Preselected Countries
DOWNLOAD

Download The Impact Of Off Label Compassionate And Unlicensed Use On Health Care Laws In Preselected Countries PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get The Impact Of Off Label Compassionate And Unlicensed Use On Health Care Laws In Preselected Countries book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page



The Impact Of Off Label Compassionate And Unlicensed Use On Health Care Laws In Preselected Countries


The Impact Of Off Label Compassionate And Unlicensed Use On Health Care Laws In Preselected Countries
DOWNLOAD
Author : Vanessa Plate
language : en
Publisher: Columbia University Press
Release Date : 2010-07-01

The Impact Of Off Label Compassionate And Unlicensed Use On Health Care Laws In Preselected Countries written by Vanessa Plate and has been published by Columbia University Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2010-07-01 with Law categories.


In times of situational therapeutic impasse, health care professionals (HCPs) are under pressure to conduct off-label, unlicensed and compassionate drug use—generally summarized under the term non-licensed drug use (NDU). Liability, contractual and penal risks pose a problem when treating a patient in a non-licensed way. There is a knowledge gap about institutional and governmental methods to resolve these problems. Different countries have developed strategies to manage NDU. Vanessa Platé gives a comprehensive overview of practices Canada, the U.S., the U.K., Japan, France, Germany, Switzerland, Austria, and the transnational E.U. A must-read for everyone interested in the discussion on how to administer the best treatment, especially regarding early access to yet unapproved treatments.



Considering The Patient In Pediatric Drug Development


Considering The Patient In Pediatric Drug Development
DOWNLOAD
Author : Klaus Rose
language : en
Publisher: Academic Press
Release Date : 2020-11-19

Considering The Patient In Pediatric Drug Development written by Klaus Rose and has been published by Academic Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-11-19 with Business & Economics categories.


Considering the Patient in Pediatric Drug Development: How Good Intentions Turned into Harm addresses a fundamental challenge in drug development and healthcare for young patients. In clinical trials and clinical practice, the term "children" is used ambiguously to confer physiological characteristics to a chronological age limit, which in reality does not exist. This book outlines why the United States (US) and European Union's (EU) regulatory authorities, pediatric academia, and the pharmaceutical industry demand, support and perform pediatric drug studies, along with the key flaws of this demand that blurs the different administrative and physiological meanings of the term "child." In addition, the book covers why most pediatric regulatory studies lack medical sense and many even harm young patients and the conflicts of interest behind pediatric drug studies. It includes relevant information about the maturation of the human body regarding absorption, distribution, metabolism and excretion of food and drugs as well as key differences between newborns, infants, older children and adolescents. Explains relevant information about the maturation of the human body regarding absorption, distribution, metabolism and excretion of food and drugs, including key differences between newborns, infants, older children and adolescents Discusses historical roots of separate drug approval in officially labeled "children" and conflicts of interest in performing and publishing "pediatric" research Helps to decipher justifications for pediatric studies to help people navigate the relevance of the information



Abuse Of Minors In Clinical Studies


Abuse Of Minors In Clinical Studies
DOWNLOAD
Author : Klaus Rose
language : en
Publisher: Ethics International Press
Release Date : 2023-11-25

Abuse Of Minors In Clinical Studies written by Klaus Rose and has been published by Ethics International Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2023-11-25 with Medical categories.


With the emergence of effective drugs and observed drug toxicities in babies, two mantras emerged: that children are therapeutic orphans, and that children are not small adults. US and EU laws demand pediatric studies as a condition for the approval of new drugs in adults. This is called “Pediatric Drug Development” (PDD). Although apparently reasonable, there are catches. Children are vulnerable at birth, but they grow and become bodily mature with puberty, well before coming of age. Minors are not another species. The 18th birthday, an administrative/ legal limit, does not correspond to a physiological change. Drugs treat the body, not the legal status. PDD results in pointless studies in bodily mature adolescents, and in exaggerated studies in younger minors. An originally well-intentioned concept results in thousands of questionable studies worldwide. This book draws attention to conflicts of interest and ethical dilemmas of PDD and questions its applicability for adolescents and minors that are no longer babies.



Intellectually Impaired People


Intellectually Impaired People
DOWNLOAD
Author : Klaus Rose
language : en
Publisher: Elsevier
Release Date : 2023-03-09

Intellectually Impaired People written by Klaus Rose and has been published by Elsevier this book supported file pdf, txt, epub, kindle and other format this book has been release on 2023-03-09 with Science categories.


Intellectually Impaired People: The Ongoing Battle addresses challenges against the background of history, changing societal environments, and current intellectual approaches and attitudes toward persons with disabilities. The book discusses national and international conventions, societal attitudes, sheltered workshops, the right of intellectually impaired persons for self-responsibility and its limitations, and the place of mentally impaired persons in the public image. Additionally, the book attempts to capture the forces that drive the changes of our conceptual frameworks. The US Tuskegee study which withheld antibiotics from black men with syphilis was not ended by scientific criticism but by a courageous man, press reports, and a changed social perception. The non-hiding of handicapped children is not the result of government orders, there are many non-resolvable dilemmas and tension between supporting, understanding, and patronizing a complex situation with many potential future avenues. Recognizes how contradictory feelings and attitudes toward impaired persons have a complex historical background Sheds light on society and our institutions that deal with disabled people and the limitations of an isolated medical approach Covers national and international conventions of mentally impaired persons



Addressing The Barriers To Pediatric Drug Development


Addressing The Barriers To Pediatric Drug Development
DOWNLOAD
Author : Institute of Medicine
language : en
Publisher: National Academies Press
Release Date : 2008-08-12

Addressing The Barriers To Pediatric Drug Development written by Institute of Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2008-08-12 with Medical categories.


Decades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that children should receive medications that have not been adequately tested for safety and efficacy, the majority of drugs prescribed for children-50 to 75 percent-have not been tested in pediatric populations. Without adequate data from such testing, prescribing drugs appropriately becomes challenging for clinicians treating children, from infancy through adolescence. Addressing the Barriers to Pediatric Drug Development is the summary of a workshop, held in Washington, D.C. on June 13, 2006, that was organized to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children.



Pediatric Drug Development


Pediatric Drug Development
DOWNLOAD
Author : Andrew E. Mulberg
language : en
Publisher: John Wiley & Sons
Release Date : 2013-05-20

Pediatric Drug Development written by Andrew E. Mulberg and has been published by John Wiley & Sons this book supported file pdf, txt, epub, kindle and other format this book has been release on 2013-05-20 with Medical categories.


Most medicines have never been adequately tested for safety and efficacy in pediatric populations and preterm, infants and children are particularly vulnerable to adverse drug reactions. Pediatric Drug Development: Concepts and Applications, Second Edition, addresses the unique challenges in conducting effective drug research and development in pediatric populations. This new edition covers the legal and ethical issues of consent and assent, the additional legal and safety protections for children, and the appropriate methods of surveillance and assessment for children of varying ages and maturity, particularly for patient reported outcomes. It includes new developments in biomarkers and surrogate endpoints, developmental pharmacology and other novel aspects of global pediatric drug development. It also encompasses the new regulatory initiatives across EU, US and ROW designed to encourage improved access to safe and effective medicines for children globally. From an international team of expert contributors Pediatric Drug Development: Concepts and Applications is the practical guide to all aspects of the research and development of safe and effective medicines for children.



Ethical And Legal Considerations In Mitigating Pandemic Disease


Ethical And Legal Considerations In Mitigating Pandemic Disease
DOWNLOAD
Author : Institute of Medicine
language : en
Publisher: National Academies Press
Release Date : 2007-07-08

Ethical And Legal Considerations In Mitigating Pandemic Disease written by Institute of Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2007-07-08 with Medical categories.


In recent public workshops and working group meetings, the Forum on Microbial Threats of the Institute of Medicine (IOM) has examined a variety of infectious disease outbreaks with pandemic potential, including those caused by influenza (IOM, 2005) and severe acute respiratory syndrome (SARS) (IOM, 2004). Particular attention has been paid to the potential pandemic threat posed by the H5N1 strain of avian influenza, which is now endemic in many Southeast Asian bird populations. Since 2003, the H5N1 subtype of avian influenza has caused 185 confirmed human deaths in 11 countries, including some cases of viral transmission from human to human (WHO, 2007). But as worrisome as these developments are, at least they are caused by known pathogens. The next pandemic could well be caused by the emergence of a microbe that is still unknown, much as happened in the 1980s with the emergence of the human immunodeficiency virus (HIV) and in 2003 with the appearance of the SARS coronavirus. Previous Forum meetings on pandemic disease have discussed the scientific and logistical challenges associated with pandemic disease recognition, identification, and response. Participants in these earlier meetings also recognized the difficulty of implementing disease control strategies effectively. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary as a factual summary of what occurred at the workshop.



Redirecting Innovation In U S Health Care


Redirecting Innovation In U S Health Care
DOWNLOAD
Author : Steven Garber
language : en
Publisher: Rand Corporation
Release Date : 2014-03-31

Redirecting Innovation In U S Health Care written by Steven Garber and has been published by Rand Corporation this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014-03-31 with History categories.


New medical technologies are a leading driver of U.S. health care spending. This report identifies promising policy options to change which medical technologies are created, with two related policy goals: (1) Reduce total health care spending with the smallest possible loss of health benefits, and (2) ensure that new medical products that increase spending are accompanied by health benefits that are worth the spending increases.



Practical Aspects Of Signal Detection In Pharmacovigilance


Practical Aspects Of Signal Detection In Pharmacovigilance
DOWNLOAD
Author : Council for International Organizations of Medical Sciences (CIOMS)
language : en
Publisher: Cioms
Release Date : 2010

Practical Aspects Of Signal Detection In Pharmacovigilance written by Council for International Organizations of Medical Sciences (CIOMS) and has been published by Cioms this book supported file pdf, txt, epub, kindle and other format this book has been release on 2010 with Drug monitoring categories.


In recent years public expectations for rapid identification and prompt management of emerging drug safety issues have grown swiftly. Over a similar timeframe, the move from paper-based adverse event reporting systems to electronic capture and rapid transmission of data has resulted in the accrual of substantial datasets capable of complex analysis and querying by industry, regulators and other public health organizations. These two drivers have created a fertile environment for pharmacovigilance scientists, information technologists and statistical experts, working together, to deliver novel approaches to detect signals from these extensive and quickly growing datasets, and to manage them appropriately. In following this exciting story, this report looks at the practical consequences of these developments for pharmacovigilance practitioners. The report provides a comprehensive resource for those considering how to strengthen their pharmacovigilance systems and practices, and to give practical advice. But the report does not specify instant solutions. These will inevitably be situation specific and require careful consideration taking into account local needs. However, the CIOMS Working Group VIII is convinced that the combination of methods and a clear policy on the management of signals will strengthen current systems. Finally, in looking ahead, the report anticipates a number of ongoing developments, including techniques with wider applicability to other data forms than individual case reports. The ultimate test for pharmacovigilance systems is the demonstration of public health benefit and it is this test which signal detection methodologies need to meet if the expectations of all stakeholders are to be fulfilled.



International Ethical Guidelines For Health Related Research Involving Humans


International Ethical Guidelines For Health Related Research Involving Humans
DOWNLOAD
Author : Council for International Organizations of Medical Sciences (CIOMS)
language : en
Publisher: World Health Organization
Release Date : 2017-01-31

International Ethical Guidelines For Health Related Research Involving Humans written by Council for International Organizations of Medical Sciences (CIOMS) and has been published by World Health Organization this book supported file pdf, txt, epub, kindle and other format this book has been release on 2017-01-31 with Bioethics categories.


"In the new 2016 version of the ethical guidelines, CIOMS provides answers to a number of pressing issues in research ethics. The Council does so by stressing the need for research having scientific and social value, by providing special guidelines for health-related research in low-resource settings, by detailing the provisions for involving vulnerable groups in research and for describing under what conditions biological samples and health-related data can be used for research."--Page 4 de la couverture.